GSK Vaccines Development Pipeline

Strengthening our R&D pipeline through a focus on science related to the immune system, the use of the human genetics, and advanced technologies

Reference

Pipeline updates: Pipeline | GSK

NX-GBL-VX-WCNT-220001 | June 2023

Get in touch

To report an adverse event or for any other information, please click the link below.

Contact us

Gsk.com

©2024 GSK group of companies or its licensor.
GlaxoSmithKline Pte Ltd, Registered in Singapore No 198102938K.
Registered Office: 23 Rochester Park Singapore 139234